Interestingly, the statistical significance in the subgroup analysis of hepatobiliary pancreatic cancer and digestive tract cancer was affirmed; meanwhile, a strong association was identified in digestive system cancer, breast cancer, lung cancer, head and neck cancer, and other cancer types included in this analysis, which indicated that CD155 might play a consistent and compatible role in various cancers. Here, PVR is linked to lung cancer.